Jackson Square Partners, LLC Edwards Lifesciences Corp Transaction History

Jackson Square Partners, LLC

$1.62 Billion
Q2 2024

A detailed history of Jackson Square Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Jackson Square Partners, LLC holds 98,062 shares of EW stock, worth $6.42 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

98,062

Previous 109,380 10.35%

Holding current value

$6.42 Million

Previous $10.5 Million 13.35%

% of portfolio

0.56%

Previous 0.44%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$84.3 - $94.31 $954,107 - $1.07 Million	-11,318 Reduced 10.35%	98,062 $9.06 Million
Q1 2024 May 08, 2024	SELL	$72.54 - $95.56 $618,983 - $815,413	-8,533 Reduced 7.24%	109,380 $10.5 Million
Q4 2023 Feb 08, 2024	SELL	$61.71 - $77.76 $1.02 Million - $1.29 Million	-16,594 Reduced 12.34%	117,913 $8.99 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $162,808 - $219,443	-2,350 Reduced 1.72%	134,507 $9.32 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $3.54 Million - $4.11 Million	-43,523 Reduced 24.13%	136,857 $12.9 Million
Q1 2023 May 11, 2023	SELL	$74.26 - $84.51 $5.88 Million - $6.69 Million	-79,209 Reduced 30.51%	180,380 $14.9 Million
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $2.76 Million - $3.54 Million	-40,433 Reduced 13.48%	259,589 $19.4 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $5.57 Million - $7.26 Million	-67,637 Reduced 18.4%	300,022 $24.8 Million
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $132 Million - $196 Million	-1,526,984 Reduced 80.59%	367,659 $35 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $6.02 Million - $7.58 Million	-59,027 Reduced 3.02%	1,894,643 $223 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $120 Million - $148 Million	-1,132,598 Reduced 36.7%	1,953,670 $253 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $38.6 Million - $46.1 Million	-375,184 Reduced 10.84%	3,086,268 $349 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $42.8 Million - $53.5 Million	-510,646 Reduced 12.86%	3,461,452 $359 Million
Q1 2021 May 13, 2021	SELL	$78.68 - $90.67 $225 Million - $259 Million	-2,860,772 Reduced 41.87%	3,972,098 $332 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $58.5 Million - $74.4 Million	816,051 Added 13.56%	6,832,870 $623 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $404 Million - $526 Million	6,016,819 New	6,016,819 $480 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Partners, LLC with notifications on news.

Account

Jackson Square Partners, LLC Edwards Lifesciences Corp Transaction History